Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 7, 2007 - Issue 11
Submit an article Journal homepage
758
Views
173
CrossRef citations to date
0
Altmetric
Review

Immunotherapy of cancer by IL-12-based cytokine combinations

Jonathan M Weiss Staff Scientist National Cancer Institute, Cancer and Infl ammation Program, Laboratory of Experimental Immunology, Center for Cancer Research, Frederick, MD 21702, USA
,
Jeff J Subleski Biologist National Cancer Institute, Cancer and Infl ammation Program, Laboratory of Experimental Immunology, Center for Cancer Research, Frederick, MD 21702, USA
,
Jon M Wigginton Director of Clinical Research/Oncology Merck Research Laboratories, North Wales, PA 19454, USA
&
Robert H Wiltrout Director of the Center for Cancer Research National Cancer Institute, Cancer and Inflammation Program, Laboratory of Experimental Immunology, Center for Cancer Research, Frederick, MD 21702, USA
Pages 1705-1721 | Published online: 26 Oct 2007

Citations (173)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Laure Lambricht, Alessandra Lopes, Spela Kos, Gregor Sersa, Véronique Préat & Gaëlle Vandermeulen. (2016) Clinical potential of electroporation for gene therapy and DNA vaccine delivery. Expert Opinion on Drug Delivery 13:2, pages 295-310.
Read now
Maria Laura Belladonna & Ursula Grohmann. (2013) Bioengineering heterodimeric cytokines: turning promiscuous proteins into therapeutic agents. Biotechnology and Genetic Engineering Reviews 29:2, pages 149-174.
Read now
José I Quetglas, Sandra Hervas-Stubbs & Cristian Smerdou. (2013) The immunological profile of tumor-bearing animals determines the outcome of cancer immunotherapy. OncoImmunology 2:6.
Read now
Elizabeth E Uhlenhake & David A Mehregan. (2011) Ustekinumab: differential use in psoriasis. Clinical, Cosmetic and Investigational Dermatology 4, pages 93-99.
Read now
Philip M Laws & Richard B Warren. (2011) Ustekinumab for the treatment of psoriasis. Expert Review of Clinical Immunology 7:2, pages 155-164.
Read now
Nora Koutruba, Jason Emer & Mark Lebwohl. (2010) Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis. Therapeutics and Clinical Risk Management 6, pages 123-141.
Read now
Megumi Maeda, Yasumitsu Nishimura, Naoko Kumagai, Hiroaki Hayashi, Tamayo Hatayama, Minako Katoh, Naomi Miyahara, Shoko Yamamoto, Junichi Hirastuka & Takemi Otsuki. (2010) Dysregulation of the immune system caused by silica and asbestos. Journal of Immunotoxicology 7:4, pages 268-278.
Read now

Articles from other publishers (166)

Margherita Sisto & Sabrina Lisi. (2023) Interleukin-23 Involved in Fibrotic Autoimmune Diseases: New Discoveries. Journal of Clinical Medicine 12:17, pages 5699.
Crossref
Elsa N. Garza Treviño, Adriana G. Quiroz Reyes, Juan Antonio Rojas Murillo, David A de la Garza Kalife, Paulina Delgado Gonzalez, Jose F. Islas, Ana Esther Estrada Rodriguez & Carlos A. Gonzalez Villarreal. (2023) Cell Therapy as Target Therapy against Colon Cancer Stem Cells. International Journal of Molecular Sciences 24:9, pages 8163.
Crossref
Nicole J. Toney, Margaret E. Gatti-Mays, Nicholas P. Tschernia, Julius Strauss, James L. Gulley, Jeffrey Schlom & Renee N. Donahue. (2023) Immune correlates with response in patients with metastatic solid tumors treated with a tumor targeting immunocytokine NHS-IL12. International Immunopharmacology 116, pages 109736.
Crossref
Antonio E. Barberio, Sean G. Smith, Ivan S. Pires, Sonia Iyer, Ferenc Reinhardt, Mariane B. Melo, Heikyung Suh, Robert A. Weinberg, Darrell J. Irvine & Paula T. Hammond. (2022) Layer‐by‐layer interleukin‐12 nanoparticles drive a safe and effective response in ovarian tumors . Bioengineering & Translational Medicine 8:2.
Crossref
Adriana G. Quiroz-Reyes, Carlos A. Gonzalez-Villarreal, Alberto Y. Limon-Flores, Paulina Delgado-Gonzalez, Herminia G. Martinez-Rodriguez, Salvador L. Said-Fernandez, Adolfo Soto-Dominguez, Ana M. Rivas-Estilla, Jose F. Islas, Juan F. Molina-De la Garza & Elsa N. Garza-Treviño. (2023) Mesenchymal Stem Cells Genetically Modified by Lentivirus-Express Soluble TRAIL and Interleukin-12 Inhibit Growth and Reduced Metastasis-Relate Changes in Lymphoma Mice Model. Biomedicines 11:2, pages 595.
Crossref
Abdolreza Esmaeilzadeh, Davood Jafari, Mahnaz Ghaebi, Reza Elahi, Farideh Afshari & Leila Karimi. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 45 .
Mohammed Moustapha Anwar, Chris Albanese, Nadia M. Hamdy & Ahmed S. Sultan. (2022) Rise of the natural red pigment ‘prodigiosin’ as an immunomodulator in cancer. Cancer Cell International 22:1.
Crossref
Wei Gao, Jun Pan & Jianping Pan. (2022) Antitumor Activities of Interleukin-12 in Melanoma. Cancers 14:22, pages 5592.
Crossref
Guilan Shi, Megan Scott, Cathryn G. Mangiamele & Richard Heller. (2022) Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma. Pharmaceutics 14:11, pages 2429.
Crossref
Yanyan Zheng, Zheng Lu, Jiage Ding, Nan Jiang, Jiawei Wang, Jie Yang, Jingyuan Song, Hongliang Chen, Lin Fang, Huizhong Li, Hui Tian, Gang Wang, Junnian Zheng & Dafei Chai. (2022) Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8+ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma. Cancers 14:18, pages 4512.
Crossref
Emily M. Cheng, Noah W. Tsarovsky, Paul M. Sondel & Alexander L. Rakhmilevich. (2022) Interleukin-12 as an in situ cancer vaccine component: a review. Cancer Immunology, Immunotherapy 71:9, pages 2057-2065.
Crossref
Elisabeth Taucher, Iurii Mykoliuk, Joerg Lindenmann & Freyja-Maria Smolle-Juettner. (2022) Implications of the Immune Landscape in COPD and Lung Cancer: Smoking Versus Other Causes. Frontiers in Immunology 13.
Crossref
Man Feng, Yang Jiang, Dongyi Liu, Guanghui Cheng, Weiquan Zhang & Chang Feng. (2022) RNA-seq analysis of peripheral blood dendritic cells maturated by dezocine in patients with lung cancer. Molecular Immunology 143, pages 85-93.
Crossref
Patrick G. Holder, Shion A. Lim, Christine S. Huang, Preeti Sharma, Yavuz S. Dagdas, Beyza Bulutoglu & Jonathan T. Sockolosky. (2022) Engineering interferons and interleukins for cancer immunotherapy. Advanced Drug Delivery Reviews 182, pages 114112.
Crossref
Alison McFarlane, Paul K. Fyfe & Ignacio Moraga. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 37 64 .
Md. Al Saber, Partha Biswas, Dipta Dey, Md. Abu Kaium, Md. Aminul Islam, Miss Ismoth Ara Tripty, MD. Hasanur Rahman, Tanjim Ishraq Rahaman, Md. Yeaman Biswas, Priyanka Paul, Md. Ataur Rahman, Md. Nazmul Hasan & Bonglee Kim. (2021) A Comprehensive Review of Recent Advancements in Cancer Immunotherapy and Generation of CAR T Cell by CRISPR-Cas9. Processes 10:1, pages 16.
Crossref
Khue G. Nguyen, Ethan S. Wagner, Maura R. Vrabel, Siena M. Mantooth, Danielle M. Meritet & David A. Zaharoff. (2021) Safety and Pharmacokinetics of Intravesical Chitosan/Interleukin-12 Immunotherapy in Murine Bladders. Bladder Cancer 7:4, pages 427-437.
Crossref
Matin Alavi, Tahereh Farkhondeh, Michael Aschner & Saeed Samarghandian. (2021) Resveratrol mediates its anti-cancer effects by Nrf2 signaling pathway activation. Cancer Cell International 21:1.
Crossref
Yanhua Li, Xiaohan Liu, Xia Zhang, Wei Pan, Na Li & Bo Tang. (2021) Immune Cycle‐Based Strategies for Cancer Immunotherapy. Advanced Functional Materials 31:50.
Crossref
Hee-Yun Kim, Hanchul Jung, Hyung-Min Kim & Hyun-Ja Jeong. (2021) Surfactin exerts an anti-cancer effect through inducing allergic reactions in melanoma skin cancer. International Immunopharmacology 99, pages 107934.
Crossref
Yee Peng Phoon, Charles Tannenbaum & C. Marcela Diaz-Montero. (2021) Immunobiology of Melanoma. Clinics in Plastic Surgery 48:4, pages 561-576.
Crossref
T. Komel, M. Bosnjak, S. Kranjc Brezar, M. De Robertis, M. Mastrodonato, G. Scillitani, G. Pesole, E. Signori, G. Sersa & M. Cemazar. (2021) Gene electrotransfer of IL-2 and IL-12 plasmids effectively eradicated murine B16.F10 melanoma. Bioelectrochemistry 141, pages 107843.
Crossref
Natalia Kułach, Ewelina Pilny, Tomasz Cichoń, Justyna Czapla, Magdalena Jarosz-Biej, Marek Rusin, Alina Drzyzga, Sybilla Matuszczak, Stanisław Szala & Ryszard Smolarczyk. (2021) Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma. Scientific Reports 11:1.
Crossref
Scott M. Norberg & Christian S. Hinrichs. (2021) Advances in Adoptive Cell Therapy for Head and Neck Cancer. Otolaryngologic Clinics of North America 54:4, pages 761-768.
Crossref
Jeong Moo Han, Ha-Yeon Song, Ho Seong Seo, Eui-Hong Byun, Seung-Taik Lim, Woo Sik Kim & Eui-Baek Byun. (2021) Immunoregulatory properties of a crude extraction fraction rich in polysaccharide from Chrysanthemum zawadskii Herbich var. latilobum and its potential role as a vaccine adjuvant. International Immunopharmacology 95, pages 107513.
Crossref
Jinyu Zhang & Xuan Zhao. (2021) Administration of fusion cytokines induces tumor regression and systemic antitumor immunity. MedComm 2:2, pages 256-268.
Crossref
Chuxin Li, Yongdan Qi, Yu Zhang, Yingge Chen, Jun Feng & Xianzheng Zhang. (2021) Artificial Engineering of Immune Cells for Improved Immunotherapy. Advanced NanoBiomed Research 1:6.
Crossref
Hye-Hyun Ahn, Christine Carrington, Yizong Hu, Heng-wen Liu, Christy Ng, Hwanhee Nam, Andrew Park, Catherine Stace, Will West, Hai-Quan Mao, Martin G. Pomper, Christopher G. Ullman & Il Minn. (2021) Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers. Scientific Reports 11:1.
Crossref
Xiaofei Zhou & Shao-Cong Sun. (2021) Targeting ubiquitin signaling for cancer immunotherapy. Signal Transduction and Targeted Therapy 6:1.
Crossref
Antonio E. Barberio, Sean G. Smith, Santiago Correa, Cathy Nguyen, Bang Nhan, Mariane Melo, Talar Tokatlian, Heikyung Suh, Darrell J. Irvine & Paula T. Hammond. (2020) Cancer Cell Coating Nanoparticles for Optimal Tumor-Specific Cytokine Delivery. ACS Nano 14:9, pages 11238-11253.
Crossref
Wamidh H. Talib, Ahmad Riyad Alsayed, Faten Farhan & Lina T. Al Kury. (2020) Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets. Molecules 25:18, pages 4282.
Crossref
Shyambabu Chaurasiya, Yuman Fong & Susanne G. Warner. (2020) Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges. Cancers 12:6, pages 1699.
Crossref
Lana E. Kandalaft, Kunle Odunsi & George Coukos. (2020) Immune Therapy Opportunities in Ovarian Cancer. American Society of Clinical Oncology Educational Book:40, pages e228-e240.
Crossref
Jahangir Ahmed, Louisa S Chard, Ming Yuan, Jiwei Wang, Anwen Howells, Yuenan Li, Haoze Li, Zhongxian Zhang, Shuangshuang Lu, Dongling Gao, Pengju Wang, Yongchao Chu, Chadwan Al Yaghchi, Joel Schwartz, Ghassan Alusi, Nicholas Lemoine & Yaohe Wang. (2020) A new oncolytic V accinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery . Journal for ImmunoTherapy of Cancer 8:1, pages e000415.
Crossref
Jieyu Li, Wansong Lin, Huijing Chen, Zhiping Xu, Yunbin Ye & Mingshui Chen. (2020) Dual-target IL-12-containing nanoparticles enhance T cell functions for cancer immunotherapy. Cellular Immunology 349, pages 104042.
Crossref
Ke‐Yu Li, Jia‐Long Yuan, Diego Trafton, Jian‐Xin Wang, Nan Niu, Chun‐Hui Yuan, Xu‐Bao Liu & Lei Zheng. (2020) Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects. Chronic Diseases and Translational Medicine 6:1, pages 6-17.
Crossref
Yu Fu, Qing Lin, Zhirong Zhang & Ling Zhang. (2020) Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity. Acta Pharmaceutica Sinica B 10:3, pages 414-433.
Crossref
Marion V Guerin, Veronica Finisguerra, Benoit J Van den Eynde, Nadege Bercovici & Alain Trautmann. (2020) Preclinical murine tumor models: A structural and functional perspective. eLife 9.
Crossref
Ling Zhang, John S Davies, Carylinda Serna, Zhiya Yu, Nicholas P Restifo, Steven A Rosenberg, Richard A Morgan & Christian S HinrichsMDMD. (2020) Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models. Journal for ImmunoTherapy of Cancer 8:1, pages e000210.
Crossref
Stefan H. Bossmann. 2020. Biomaterials for Cancer Therapeutics. Biomaterials for Cancer Therapeutics 233 259 .
Lucien P. Garo & Murugaiyan Gopal. 2020. Cancer Immunology. Cancer Immunology 205 233 .
Hong Luo, Xiuqi Wu, Ruixin Sun, Jingwen Su, Yi Wang, Yiwei Dong, Bizhi Shi, Yansha Sun, Hua Jiang & Zonghai Li. (2019) Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells. Frontiers in Oncology 9.
Crossref
Anna Maria Gasparri, Angelina Sacchi, Veronica Basso, Filippo Cortesi, Massimo Freschi, Eltjona Rrapaj, Matteo Bellone, Giulia Casorati, Paolo Dellabona, Anna Mondino, Angelo Corti & Flavio Curnis. (2019) Boosting Interleukin‐12 Antitumor Activity and Synergism with Immunotherapy by Targeted Delivery with isoDGR‐Tagged Nanogold. Small 15:45.
Crossref
Lana E. Kandalaft, Kunle Odunsi & George Coukos. (2019) Immunotherapy in Ovarian Cancer: Are We There Yet?. Journal of Clinical Oncology 37:27, pages 2460-2471.
Crossref
Jean-Charles Nault, Massih Ningarhari, Sandra Rebouissou & Jessica Zucman-Rossi. (2019) The role of telomeres and telomerase in cirrhosis and liver cancer. Nature Reviews Gastroenterology & Hepatology 16:9, pages 544-558.
Crossref
Adal H. Mirza, Gareth Thomas, Christian H. Ottensmeier & Emma V. King. (2019) Importance of the immune system in head and neck cancer. Head & Neck 41:8, pages 2789-2800.
Crossref
Noor Momin, Naveen K. Mehta, Nitasha R. Bennett, Leyuan Ma, Joseph R. Palmeri, Magnolia M. Chinn, Emi A. Lutz, Byong Kang, Darrell J. Irvine, Stefani Spranger & K. Dane Wittrup. (2019) Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy. Science Translational Medicine 11:498.
Crossref
Ole Audun Werner Haabeth, Timothy R. Blake, Colin J. McKinlay, Anders A. Tveita, Adrienne Sallets, Robert M. Waymouth, Paul A. Wender & Ronald Levy. (2019) Local Delivery of Ox40l , Cd80 , and Cd86 mRNA Kindles Global Anticancer Immunity . Cancer Research 79:7, pages 1624-1634.
Crossref
Devika Rao, Ruwan Parakrama, Titto Augustine, Qiang Liu, Sanjay Goel & Radhashree Maitra. (2019) Immunotherapeutic advances in gastrointestinal malignancies. npj Precision Oncology 3:1.
Crossref
Kadri Künnapuu, Kadi-Liis Veiman, Ly Porosk, Evelin Rammul, Kristina Kiisholts, Ülo Langel & Kaido Kurrikoff. (2019) Tumor gene therapy by systemic delivery of plasmid DNA with cell-penetrating peptides. FASEB BioAdvances 1:2, pages 105-114.
Crossref
Alireza Mohebbi, Mir Saeed Ebrahimzadeh, Sanaz Baghban Rahimi, Mohsen Saeidi, Alijan Tabarraei, Seyed Reza Mohebbi, Sadegh Shirian, Ali Gorji & Amir Ghaemi. (2019) Non-replicating Newcastle Disease Virus as an adjuvant for DNA vaccine enhances antitumor efficacy through the induction of TRAIL and granzyme B expression. Virus Research 261, pages 72-80.
Crossref
Yi Wang, Yao‐Xin Lin, Sheng‐Lin Qiao, Jie Wang & Hao Wang. (2018) Progress in Tumor‐Associated Macrophages: From Bench to Bedside. Advanced Biosystems 3:2.
Crossref
Jennifer A. Bridge, James C. Lee, Adil Daud, James W. Wells & Jeffrey A. Bluestone. (2018) Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer. Frontiers in Medicine 5.
Crossref
Gregory E Holt & Pirouz Daftarian. (2018) Non-small-cell lung cancer homing peptide-labeled dendrimers selectively transfect lung cancer cells. Immunotherapy 10:16, pages 1349-1360.
Crossref
Jinyu Zhang, Haochen Jiang & Haiyun Zhang. (2018) In situ administration of cytokine combinations induces tumor regression in mice. EBioMedicine 37, pages 38-46.
Crossref
Vishakha Bhurani & Sarat Kumar Dalai. 2018. Immunoregulatory Aspects of Immunotherapy. Immunoregulatory Aspects of Immunotherapy.
Yi-Eun Kim, Eun-Ji Cho, Hyeong-Kwang Jun, Gi-Hyung Ryu, Nak-Yun Sung & Eui-Hong Byun. (2018) Immunological Activity of Vegetable Soup Made by Extruded Radish. Food Engineering Progress 22:2, pages 161-172.
Crossref
Dae won Kim & Adi Diab. 2018. Immunotherapy in Translational Cancer Research. Immunotherapy in Translational Cancer Research 115 131 .
Efimia Boutsikou, Kalliopi Domvri, Georgia Hardavella, Dora Tsiouda, Konstantinos Zarogoulidis & Theodoros Kontakiotis. (2018) Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice. Therapeutic Advances in Medical Oncology 10, pages 175883591876823.
Crossref
Vikrant Rai, Joe Abdo, Abdullah N. Alsuwaidan, Swati Agrawal, Poonam Sharma & Devendra K. Agrawal. (2017) Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma. Molecular and Cellular Biochemistry 437:1-2, pages 13-36.
Crossref
Xiaoxiao Liu, Xiang Gao, Songping Zheng, Bilan Wang, Yanyan Li, Chanjuan Zhao, Yagmur Muftuoglu, Song Chen, Ying Li, Haiyan Yao, Hui Sun, Qing Mao, Chao You, Gang Guo & Yuquan Wei. (2017) Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer. Nanomedicine: Nanotechnology, Biology and Medicine 13:6, pages 1993-2004.
Crossref
Shengwen Shao, Eric Risch, Danielle Burner, Lingeng Lu, Boris Minev & Wenxue Ma. (2017) IFNγ enhances cytotoxic efficiency of the cytotoxic T lymphocytes against human glioma cells. International Immunopharmacology 47, pages 159-165.
Crossref
Ho-Young Park, Taek Joon Yoon, Wookyung Lee, Yoonsook Kim & Hee-Don Choi. (2017) Antimetastatic effect of glycoprotein isolated from rice bran on colon 26-M3.1 cell line. Journal of Functional Foods 32, pages 278-284.
Crossref
Eonju Oh, Il-Kyu Choi, JinWoo Hong & Chae-Ok Yun. (2016) Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model. Oncotarget 8:3, pages 4730-4746.
Crossref
Howard L. Kaufman & Neal Dharmadhikari. 2017. Cancer Therapeutic Targets. Cancer Therapeutic Targets 345 359 .
Katarina M. Mirjačić Martinović, Nada Lj. Babović, Radan R. Džodić, Vladimir B. Jurišić, Aleksandra Z. Ninković & Gordana M. Konjević. (2016) Beneficial in-vitro effects of interleukin-2, interleukin-12, and their combination on functional and receptor characteristics of natural killer cells in metastatic melanoma patients with normal serum lactate dehydrogenase levels. Melanoma Research 26:6, pages 551-564.
Crossref
RaeAnna Wilson, Cristina Espinosa-Diez, Nathan Kanner, Namita Chatterjee, Rebecca Ruhl, Christina Hipfinger, Sunil J. Advani, Jie Li, Omar F. Khan, Aleksandra Franovic, Sara M. Weis, Sushil Kumar, Lisa M. Coussens, Daniel G. Anderson, Clark C. Chen, David A. Cheresh & Sudarshan Anand. (2016) MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment. Nature Communications 7:1.
Crossref
Bora Jang, Hyokyoung Kwon, Pramila Katila, Seung Jin Lee & Hyukjin Lee. (2016) Dual delivery of biological therapeutics for multimodal and synergistic cancer therapies. Advanced Drug Delivery Reviews 98, pages 113-133.
Crossref
Eun-Jung Lee, Seo Jin Lee, Ji-Hye Kim, Kyoung-Jin Kim, Seung-Hyun Yang, Keun-Yeong Jeong & Jinsil Seong. (2016) Radiation Inhibits Interleukin-12 Production via Inhibition of C-Rel through the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Signaling Pathway in Dendritic Cells. PLOS ONE 11:1, pages e0146463.
Crossref
Anand Rotte & Madhuri BhandaruAnand Rotte & Madhuri Bhandaru. 2016. Immunotherapy of Melanoma. Immunotherapy of Melanoma 351 416 .
Witold Lasek & Radoslaw ZagozdzonWitold Lasek & Radoslaw Zagozdzon. 2016. Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology. Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology 43 75 .
Witold Lasek & Radoslaw ZagozdzonWitold Lasek & Marek Jakóbisiak. 2016. Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology. Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology 21 41 .
Witold Lasek & Radoslaw ZagozdzonRadoslaw Zagozdzon & Witold Lasek. 2016. Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology. Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology 1 19 .
Carol Shoshkes Reiss. 2016. Neurotropic Viral Infections. Neurotropic Viral Infections 251 303 .
Howard L. Kaufman & Neal Dharmadhikari. 2016. Cancer Therapeutic Targets. Cancer Therapeutic Targets 1 15 .
Federica Maria Di Maggio, Luigi Minafra, Giusi Irma Forte, Francesco Paolo Cammarata, Domenico Lio, Cristina Messa, Maria Carla Gilardi & Valentina Bravatà. (2015) Portrait of inflammatory response to ionizing radiation treatment. Journal of Inflammation 12:1.
Crossref
M. Gabriela Kramer, Martín Masner, Erkuden Casales, María Moreno, Cristian Smerdou & José A. Chabalgoity. (2015) Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice. BMC Cancer 15:1.
Crossref
Stephanie C. Casey, Amedeo Amedei, Katia Aquilano, Asfar S. Azmi, Fabian Benencia, Dipita Bhakta, Alan E. Bilsland, Chandra S. Boosani, Sophie Chen, Maria Rosa Ciriolo, Sarah Crawford, Hiromasa Fujii, Alexandros G. Georgakilas, Gunjan Guha, Dorota Halicka, William G. Helferich, Petr Heneberg, Kanya Honoki, W. Nicol Keith, Sid P. Kerkar, Sulma I. Mohammed, Elena Niccolai, Somaira Nowsheen, H.P. Vasantha Rupasinghe, Abbas Samadi, Neetu Singh, Wamidh H. Talib, Vasundara Venkateswaran, Richard L. Whelan, Xujuan Yang & Dean W. Felsher. (2015) Cancer prevention and therapy through the modulation of the tumor microenvironment. Seminars in Cancer Biology 35, pages S199-S223.
Crossref
Magdalena Jarosz-Biej, Ryszard Smolarczyk, Tomasz Cicho?Natalia Ku?ach, Justyna Czapla, Sybilla Matuszczak & Stanis?aw Szala. (2015) Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in Mice. Archivum Immunologiae et Therapiae Experimentalis 63:6, pages 451-464.
Crossref
C Lorenzo, G Pérez-Chacón, G Garaulet, Z Mallorquín, J M Zapata & A Rodríguez. (2015) Efficient expression of bioactive murine IL12 as a self-processing P2A polypeptide driven by inflammation-regulated promoters in tumor cell lines. Cancer Gene Therapy 22:11, pages 542-551.
Crossref
Elisabetta Radice, Graziella Bellone & Vincenzo Miranda. (2015) Enhancement of the Immunostimulatory Functions of Ex Vivo–Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study. Translational Oncology 8:4, pages 327-338.
Crossref
Sean G. Smith, Bhanu prasanth Koppolu, Sruthi Ravindranathan, Samantha L. Kurtz, Lirong Yang, Matthew D. Katz & David A. Zaharoff. (2015) Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer. Cancer Immunology, Immunotherapy 64:6, pages 689-696.
Crossref
Suk Ran Yoon, Tae-Don Kim & Inpyo Choi. (2015) Understanding of molecular mechanisms in natural killer cell therapy. Experimental & Molecular Medicine 47:2, pages e141-e141.
Crossref
S Tugues, S H Burkhard, I Ohs, M Vrohlings, K Nussbaum, J vom Berg, P Kulig & B Becher. (2014) New insights into IL-12-mediated tumor suppression. Cell Death & Differentiation 22:2, pages 237-246.
Crossref
Hironori Nishitsuji, Kenji Funami, Yuko Shimizu, Saneyuki Ujino, Tsukasa Seya & Kunitada Shimotohno. 2015. Inflammation and Immunity in Cancer. Inflammation and Immunity in Cancer 109 121 .
Murugaiyan Gopal. 2015. Cancer Immunology. Cancer Immunology 93 119 .
Bo-Kyeong Kang, Koth-Bong-Woo-Ri Kim, Na-Kyung Ahn, Yeon-Uk Choi, Min-Ji Kim, Si-Woo Bark, Won-Min Pak, Bo-Ram Kim, Ji-Hye Park, Nan-Young Bae & Dong-Hyun Ahn. (2014) Immuno-stimulating Activities of Skipjack Tuna Katsuwonus pelamis Cooking Juice Concentrates on Mouse Macrophages and Spleen Cells. Korean Journal of Fisheries and Aquatic Sciences 47:6, pages 776-784.
Crossref
Witold Lasek, Rados?aw Zago?d?on & Marek Jakobisiak. (2014) Interleukin 12: still a promising candidate for tumor immunotherapy?. Cancer Immunology, Immunotherapy 63:5, pages 419-435.
Crossref
John Koo, Ethan Levin, Argentina Leon, Jashin Wu & Alice GottliebAndrew Blauvelt. 2014. Moderate to Severe Psoriasis, Fourth Edition. Moderate to Severe Psoriasis, Fourth Edition 217 230 .
Juan R. Rodriguez-MadozMaider ZabalaMaite AlfaroJesus PrietoM. Gabriela KramerCristian Smerdou. (2014) Short-Term Intratumoral Interleukin-12 Expressed from an Alphaviral Vector Is Sufficient to Induce an Efficient Antitumoral Response Against Spontaneous Hepatocellular Carcinomas. Human Gene Therapy 25:2, pages 132-143.
Crossref
James K. Coleman, Ruiyu Pu, Marcus M. Martin, Ezra N. Noon-Song, Raphael Zwijnenberg & Janet K. Yamamoto. (2014) Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies. Vaccine 32:6, pages 746-754.
Crossref
Tim Chan, Jonathan Lewis & Ronald B. Herberman. 2014. Gene Therapy of Cancer. Gene Therapy of Cancer 363 376 .
Benjamin Frey, Yvonne Rubner, Lorenz Kulzer, Nina Werthmöller, Eva-Maria Weiss, Rainer Fietkau & Udo S. Gaipl. (2013) Antitumor immune responses induced by ionizing irradiation and further immune stimulation. Cancer Immunology, Immunotherapy 63:1, pages 29-36.
Crossref
Jin Woo Hur, Eun Hee Cho, Bo Kyung Lee, Uiyoung Lee & Taek Joon Yoon. (2013) The Enhanced Effect of Oplopanax elatus Nakai on the Immune System and Antitumor Activity. The Korean Journal of Food And Nutrition 26:3, pages 375-382.
Crossref
Sid P Kerkar, Anthony J Leonardi, Nicolas van Panhuys, Ling Zhang, Zhiya Yu, Joseph G Crompton, Jenny H Pan, Douglas C Palmer, Richard A Morgan, Steven A Rosenberg & Nicholas P Restifo. (2013) Collapse of the Tumor Stroma is Triggered by IL-12 Induction of Fas. Molecular Therapy 21:7, pages 1369-1377.
Crossref
Chi-Chen Hong, Song Yao, Susan E. McCann, Ree Y. Dolnick, Paul K. Wallace, Zhihong Gong, Lei Quan, Kelvin P. Lee, Sharon S. Evans, Elizabeth A. Repasky, Stephen B. Edge & Christine B. Ambrosone. (2013) Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers. Breast Cancer Research and Treatment 139:2, pages 477-488.
Crossref
M. Barhoumi, A. Meddeb‐Garnaoui, N. K. Tanner, J. Banroques, B. Kaabi & I. Guizani. (2013) DEAD‐box proteins, like Leishmania eIF4A, modulate interleukin (IL)‐12, IL‐10 and tumour necrosis factor‐alpha production by human monocytes . Parasite Immunology 35:5-6, pages 194-199.
Crossref
Oliwia Andries, Marina De Filette, Stefaan C. De Smedt, Jo Demeester, Mario Van Poucke, Luc Peelman & Niek N. Sanders. (2013) Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells. Journal of Controlled Release 167:2, pages 157-166.
Crossref
Hui Zhong & Karina Yazdanbakhsh. (2013) Differential control of Helios+/− Treg development by monocyte subsets through disparate inflammatory cytokines. Blood 121:13, pages 2494-2502.
Crossref
Jose I. Quetglas, Juan R. Rodriguez-Madoz, Jaione Bezunartea, Marta Ruiz-Guillen, Erkuden Casales, Jose Medina-Echeverz, Jesus Prieto, Pedro Berraondo, Sandra Hervas-Stubbs & Cristian Smerdou. (2013) Eradication of Liver-Implanted Tumors by Semliki Forest Virus Expressing IL-12 Requires Efficient Long-Term Immune Responses. The Journal of Immunology 190:6, pages 2994-3004.
Crossref
Rashmi Jalah, Margherita Rosati, Brunda Ganneru, Guy R. Pilkington, Antonio Valentin, Viraj Kulkarni, Cristina Bergamaschi, Bhabadeb Chowdhury, Gen-Mu Zhang, Rachel Kelly Beach, Candido Alicea, Kate E. Broderick, Niranjan Y. Sardesai, George N. Pavlakis & Barbara K. Felber. (2013) The p40 Subunit of Interleukin (IL)-12 Promotes Stabilization and Export of the p35 Subunit. Journal of Biological Chemistry 288:9, pages 6763-6776.
Crossref
Yuri Kogan, Zvia Agur & Moran Elishmereni. (2013) A mathematical model for the immunotherapeutic control of the Th1/Th2 imbalance in melanoma. Discrete and Continuous Dynamical Systems - Series B 18:4, pages 1017-1030.
Crossref
Gopal Murugaiyan & Bhaskar Saha. (2013) IL-27 in tumor immunity and immunotherapy. Trends in Molecular Medicine 19:2, pages 108-116.
Crossref
Kalamegam Gauthaman, Chui‐Yee Fong, Suganya Arularasu, Arjunan Subramanian, Arijit Biswas, Mahesh Choolani & Ariff Bongso. (2012) Human Wharton's Jelly stem cell conditioned medium and cell‐free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice. Journal of Cellular Biochemistry 114:2, pages 366-377.
Crossref
Hoyong LimSeon Ah DoSang Min ParkYoung Sang Kim. (2013) Tumor Cell Clone Expressing the Membrane-bound Form of IL-12p35 Subunit Stimulates Antitumor Immune Responses Dominated by CD8 + T Cells . Immune Network 13:2, pages 63.
Crossref
Jason J. Emer, Amir Larian & Mark G. Lebwohl. 2013. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy 319 332.e2 .
Paola Brun, Barbara Zavan, Vincenzo Vindigni, Antonella Schiavinato, Assunta Pozzuoli, Claudio Iacobellis & Giovanni Abatangelo. (2012) In vitro response of osteoarthritic chondrocytes and fibroblast-like synoviocytes to a 500-730 kDa hyaluronan amide derivative . Journal of Biomedical Materials Research Part B: Applied Biomaterials 100B:8, pages 2073-2081.
Crossref
Elham Mohit & Sima Rafati. (2012) Chemokine-based immunotherapy: delivery systems and combination therapies. Immunotherapy 4:8, pages 807-840.
Crossref
Jaehyup Kim, Ryan A. Denu, Bridget A. Dollar, Leah E. Escalante, Justin P. Kuether, Natalie S. Callander, Fotis Asimakopoulos & Peiman Hematti. (2012) Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells. British Journal of Haematology 158:3, pages 336-346.
Crossref
B Hong, G Peng, L Berry, S Gottschalk, J U Jung, S-Y Chen & X F Huang. (2011) Generating CTLs against the subdominant EBV LMP antigens by transient expression of an A20 inhibitor with EBV LMP proteins in human DCs. Gene Therapy 19:8, pages 818-827.
Crossref
Min Cheng, Baozhen Fei, Xiaodong Zheng, Yongyan Chen, Rui Sun, Haiming Wei & Zhigang Tian. (2012) A new reliable bioassay for determining the biological activity of human interleukin-12 by using human NK cell line NKG cells. International Immunopharmacology 13:1, pages 109-113.
Crossref
Douglas W. McMillin, Jake Delmore, Joseph M. Negri, Matthew Vanneman, Shohei Koyama, Robert L. Schlossman, Nikhil C. Munshi, Jacob Laubach, Paul G. Richardson, Glenn Dranoff, Kenneth C. Anderson & Constantine S. Mitsiades. (2012) Compartment-specific bioluminescence imaging platform for the high-throughput evaluation of antitumor immune function. Blood 119:15, pages e131-e138.
Crossref
Chun Huang, Rupal Ramakrishnan, Marko Trkulja, Xiubao Ren & Dmitry I. Gabrilovich. (2012) Therapeutic effect of intratumoral administration of DCs with conditional expression of combination of different cytokines. Cancer Immunology, Immunotherapy 61:4, pages 573-579.
Crossref
Tim Chan, Timothy C. Back, Jeffrey J. Subleski, Jonathan M. Weiss, John R. Ortaldo & Robert H. Wiltrout. (2012) Systemic IL-12 Administration Alters Hepatic Dendritic Cell Stimulation Capabilities. PLoS ONE 7:3, pages e33303.
Crossref
R?za ?nder G?nayd?n, Sacit Altu? Kesikli, Emin Kansu & Ali ?efik Ho?al. (2012) Identification of the peripheral blood levels of interleukin-12, interleukin-10, and transforming growth factor-? in patients with laryngeal squamous cell carcinoma. Head & Neck 34:3, pages 393-397.
Crossref
Seon-Young Kim, Jae-Min Kim, Sung-Wan Kim, Il-Seon Shin, Min-Ho Park, Jung-Han Yoon, Chan Choi & Jin-Sang Yoon. (2012) Associations between Plasma Cytokines and Depressive Mood in Patients with Breast Cancer. The International Journal of Psychiatry in Medicine 43:1, pages 1-17.
Crossref
Zhao-Quan Huang, Jun-Li Wang, Guo-Gang Pan & Ye-Sheng Wei. (2012) Association of single nucleotide polymorphisms in IL-12 and IL-27 genes with colorectal cancer risk. Clinical Biochemistry 45:1-2, pages 54-59.
Crossref
Michael J. Corbley. 2012. Signaling Pathways in Cancer Pathogenesis and Therapy. Signaling Pathways in Cancer Pathogenesis and Therapy 109 144 .
Sid P. Kerkar, Romina S. Goldszmid, Pawel Muranski, Dhanalakshmi Chinnasamy, Zhiya Yu, Robert N. Reger, Anthony J. Leonardi, Richard A. Morgan, Ena Wang, Francesco M. Marincola, Giorgio Trinchieri, Steven A. Rosenberg & Nicholas P. Restifo. (2011) IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. Journal of Clinical Investigation 121:12, pages 4746-4757.
Crossref
Judith Leibovici, Orit Itzhaki, Monica Huszar & Judith Sinai. (2011) The tumor microenvironment: part 1. Immunotherapy 3:11, pages 1367-1384.
Crossref
Duncan B Sutherland, Charani Ranasinghe, Matthias Regner, Simon Phipps, Klaus I Matthaei, Stephanie L Day & Ian A Ramshaw. (2010) Evaluating vaccinia virus cytokine co‐expression in TLR GKO mice. Immunology & Cell Biology 89:6, pages 706-715.
Crossref
Jianping Li, Qinjun Zhao, Wen Xing, Jianming Feng, Hao Wu, Huiyuan Li, Meili Ge, Kun Tian, Xingxin Li, Jianfeng Zhou, Bin Liu, Lei Zhang, Yizhou Zheng & Zhong C. Han. (2011) Interleukin-27 enhances the production of tumour necrosis factor-? and interferon-? by bone marrow T lymphocytes in aplastic anaemia. British Journal of Haematology 153:6, pages 764-772.
Crossref
Ling Zhang, Sid P Kerkar, Zhiya Yu, Zhili Zheng, Shicheng Yang, Nicholas P Restifo, Steven A Rosenberg & Richard A Morgan. (2011) Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment. Molecular Therapy 19:4, pages 751-759.
Crossref
Chui-Yee Fong, Li-Ling Chak, Arijit Biswas, Jee-Hian Tan, Kalamegam Gauthaman, Woon-Khiong Chan & Ariff Bongso. (2010) Human Wharton’s Jelly Stem Cells Have Unique Transcriptome Profiles Compared to Human Embryonic Stem Cells and Other Mesenchymal Stem Cells. Stem Cell Reviews and Reports 7:1, pages 1-16.
Crossref
Bruce Ruggeri. (2011) Cellular and Animal Models in Oncology and Tumor Biology. Current Protocols in Pharmacology 52:1.
Crossref
Marc Baay, Anja Brouwer, Patrick Pauwels, Marc Peeters & Filip Lardon. (2011) Tumor Cells and Tumor-Associated Macrophages: Secreted Proteins as Potential Targets for Therapy. Clinical and Developmental Immunology 2011, pages 1-12.
Crossref
Megan Nelles, Vincenzo Salerno, Yixin Xu & Christopher J. Paige. 2011. Experimental and Applied Immunotherapy. Experimental and Applied Immunotherapy 281 305 .
Eric Tran, Julie S. Nielsen, Darin A. Wick, Alvin V. Ng, Lisa D. S. Johnson, Nancy J. Nesslinger, Elissa McMurtrie, John R. Webb & Brad H. Nelson. (2010) Polyfunctional T-Cell Responses Are Disrupted by the Ovarian Cancer Ascites Environment and Only Partially Restored by Clinically Relevant Cytokines. PLoS ONE 5:12, pages e15625.
Crossref
M Ahmed, S Puckett & D S Lyles. (2010) Susceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virus. Cancer Gene Therapy 17:12, pages 883-892.
Crossref
Michael Conzelmann, Andreas H. Wagner, Anke Hildebrandt, Elena Rodionova, Michael Hess, Annika Zota, Thomas Giese, Christine S. Falk, Anthony D. Ho, Peter Dreger, Markus Hecker & Thomas Luft. (2010) IFN-γ activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 production. Biochemical Pharmacology 80:12, pages 2074-2086.
Crossref
Marganit Benish & Shamgar Ben-Eliyahu. (2010) Surgery as a Double-Edged Sword: A Clinically Feasible Approach to Overcome the Metastasis-Promoting Effects of Surgery by Blunting Stress and Prostaglandin Responses. Cancers 2:4, pages 1929-1951.
Crossref
Hiroshi Nagai, Shuntaro Oniki, Susumu Fujiwara, Takayuki Yoshimoto & Chikako Nishigori. (2010) Antimelanoma immunotherapy: clinical and preclinical applications of IL-12 family members. Immunotherapy 2:5, pages 697-709.
Crossref
Sid P. Kerkar, Pawel Muranski, Andrew Kaiser, Andrea Boni, Luis Sanchez-Perez, Zhiya Yu, Douglas C. Palmer, Robert N. Reger, Zachary A. Borman, Ling Zhang, Richard A. Morgan, Luca Gattinoni, Steven A. Rosenberg, Giorgio Trinchieri & Nicholas P. Restifo. (2010) Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts. Cancer Research 70:17, pages 6725-6734.
Crossref
Mike W. Helms, Jennifer A. Prescher, Yu-An Cao, Steven Schaffert & Christopher H. Contag. (2010) IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy. Cancer Immunology, Immunotherapy 59:9, pages 1325-1334.
Crossref
Glenda Canderan, Paola Gruarin, Daniela Montagna, Raffaella Fontana, Giulio Melloni, Catia Traversari, Paolo Dellabona & Giulia Casorati. (2010) An Efficient Strategy to Induce and Maintain In Vitro Human T Cells Specific for Autologous Non-Small Cell Lung Carcinoma. PLoS ONE 5:8, pages e12014.
Crossref
S D Reed, A Fulmer, J Buckholz, B Zhang, J Cutrera, K Shiomitsu & S Li. (2010) Bleomycin/interleukin-12 electrochemogenetherapy for treating naturally occurring spontaneous neoplasms in dogs. Cancer Gene Therapy 17:8, pages 571-578.
Crossref
D Stevanovic, M Sumarac-Dumanovic, D Micic & V Trajkovic. (2010) Reply to Chen. International Journal of Obesity 34:7, pages 1229-1229.
Crossref
S D Reed, A Fulmer, J Buckholz, B Zhang, J Cutrera, K Shiomitsu & S Li. (2010) Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs. Cancer Gene Therapy 17:7, pages 457-464.
Crossref
Ryszard Smolarczyk, Tomasz Cichoń, Wojciech Kamysz, Magdalena Głowala-Kosińska, Anna Szydło, Łukasz Szultka, Aleksander L Sieroń & Stanisław Szala. (2010) Anticancer effects of CAMEL peptide. Laboratory Investigation 90:6, pages 940-952.
Crossref
Christoph Schlapbach, Andr? Ochsenbein, Ursula Kaelin, Akmal S. Hassan, Robert E. Hunger & Nikhil Yawalkar. (2010) High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology 62:6, pages 995-1004.
Crossref
Trevor T. Hansel, Harald Kropshofer, Thomas Singer, Jane A. Mitchell & Andrew J. T. George. (2010) The safety and side effects of monoclonal antibodies. Nature Reviews Drug Discovery 9:4, pages 325-338.
Crossref
Nicholas Butowski. (2010) Immunostimulants for Malignant Gliomas. Neurosurgery Clinics of North America 21:1, pages 53-65.
Crossref
Curtis J. Henry, Jason M. Grayson, Kristina L. Brzoza-Lewis, Latoya M. Mitchell, Marlena M. Westcott, Anne S. Cook & Elizabeth M. Hiltbold. (2010) The roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: Insights from a DC vaccination model. Cellular Immunology 264:1, pages 23-31.
Crossref
Jeff Subleski, Jonathan M. Weiss, Robert H. Wiltrout & John R. Ortaldo. 2010. Natural Killer Cells. Natural Killer Cells 255 277 .
Deborah L. S. Goetz & William J. Murphy. 2010. Natural Killer Cells. Natural Killer Cells 199 219 .
Janet B. Clarke. 2010. Adverse Drug Reactions. Adverse Drug Reactions 453 474 .
Junzo Hamanishi, Masaki Mandai, Noriomi Matsumura, Tsukasa Baba, Ken Yamaguchi, Shingo Fujii & Ikuo Konishi. (2010) Activated Local Immunity by CC Chemokine Ligand 19-Transduced Embryonic Endothelial Progenitor Cells Suppresses Metastasis of Murine Ovarian Cancer  . Stem Cells 28:1, pages 164-173.
Crossref
Bruce Ruggeri. (2009) Cellular and Animal Models in Oncology and Tumor Biology. Current Protocols in Pharmacology 47:1.
Crossref
Jeff J. Subleski, Robert H. Wiltrout & Jonathan M. Weiss. (2009) Application of tissue-specific NK and NKT cell activity for tumor immunotherapy. Journal of Autoimmunity 33:3-4, pages 275-281.
Crossref
Bangxing Hong, Wenhong Ren, Xiao-Tong Song, Kevin Evel-Kabler, Si-Yi Chen & Xue F. Huang. (2009) Human Suppressor of Cytokine Signaling 1 Controls Immunostimulatory Activity of Monocyte-Derived Dendritic Cells. Cancer Research 69:20, pages 8076-8084.
Crossref
Roberto Ronca, Silvano Sozzani, Marco Presta & Patrizia Alessi. (2009) Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case. Immunobiology 214:9-10, pages 800-810.
Crossref
L. M. Skivka, G. V. Gorbik, O. G. Fedorchuk & V. V. Pozur. (2009) Tumor-associated macrophages in the prospect of development of targeted anticancer. Cytology and Genetics 43:4, pages 283-292.
Crossref
Ye‐Sheng Wei, Yan Lan, Bin Luo, Dong Lu & Hong‐Bing Nong. (2009) Association of variants in the interleukin‐27 and interleukin‐12 gene with nasopharyngeal carcinoma. Molecular Carcinogenesis 48:8, pages 751-757.
Crossref
Jason G. Fewell, Majed M. Matar, Jennifer S. Rice, Elaine Brunhoeber, Gregory Slobodkin, Casey Pence, Miranda Worker, Danny H. Lewis & Khursheed Anwer. (2009) Treatment of disseminated ovarian cancer using nonviral interleukin‐12 gene therapy delivered intraperitoneally. The Journal of Gene Medicine 11:8, pages 718-728.
Crossref
Nigel S. Courtenay-Luck & David Jones. 2009. Recombinant Antibodies for Immunotherapy. Recombinant Antibodies for Immunotherapy 190 200 .
Bang ZhaoLan-Qing MengHai-Neng HuangYun PanQun-Qing Xu. (2009) A Novel Functional Polymorphism, 16974 A/C, in the Interleukin-12 -3′ Untranslated Region Is Associated with Risk of Glioma . DNA and Cell Biology 28:7, pages 335-341.
Crossref
Thi Lien-Anh Nguyen, Vanessa Fonseca Tumilasci, Diane Singhroy, Meztli Arguello & John Hiscott. (2009) The emergence of combinatorial strategies in the development of RNA oncolytic virus therapies. Cellular Microbiology 11:6, pages 889-897.
Crossref
Jun Dou, Yongfang Wang, Jing Wang, Fengshu Zhao, Yating Li, Minggang Cao, Weihua Hu, Kai Hu, Xiang Feng He, Lili Chu, Chuilian Jiang & Ning Gu. (2009) Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model. Immunobiology 214:6, pages 483-492.
Crossref
Angela M Bodles-Brakhop, Richard Heller & Ruxandra Draghia-Akli. (2009) Electroporation for the Delivery of DNA-based Vaccines and Immunotherapeutics: Current Clinical Developments. Molecular Therapy 17:4, pages 585-592.
Crossref
. (2009) Current World Literature. Current Opinion in Obstetrics & Gynecology 21:1, pages 101-109.
Crossref
Phillip Moheno, Wolfgang Pfleiderer & Dietmar Fuchs. (2009) Plasma cytokine concentration changes induced by the antitumor agents dipterinyl calcium pentahydrate (DCP) and related calcium pterins. Immunobiology 214:2, pages 135-141.
Crossref
Basel K. al-Ramadi, Maria J. Fernandez-Cabezudo, Hussain El-Hasasna, Suhail Al-Salam, Ghada Bashir & Salem Chouaib. (2009) Potent anti-tumor activity of systemically-administered IL2-expressing Salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis. Clinical Immunology 130:1, pages 89-97.
Crossref
Kapil Mehta, Bulent Ozpolat, Kishorchandra Gohil & Bharat B. Aggarwal. 2009. Principles of Cancer Biotherapy. Principles of Cancer Biotherapy 53 83 .
Jeffry Cutrera & Shulin Li. 2009. Targeted Cancer Immune Therapy. Targeted Cancer Immune Therapy 97 113 .
Andrew Blauvelt. 2008. Moderate-to-Severe Psoriasis, Third Edition. Moderate-to-Severe Psoriasis, Third Edition 347 364 .
H Wang & T C Thompson. (2008) Gene-modified bone marrow cell therapy for prostate cancer. Gene Therapy 15:10, pages 787-796.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.